An insight into the medicinal chemistry perspective of macrocyclic derivatives with antitumor activity: asystematic review

HIGHLIGHTS

• who: Yan Liang and colleagues from the Department of Pathology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China have published the article: An Insight into the Medicinal Chemistry Perspective of Macrocyclic Derivatives with Antitumor Activity: ASystematic Review, in the Journal: Molecules 2022, 27, x FOR REVIEW Molecules 2022, 27, xPEER FOR PEER REVIEW Molecules 2022,27, 27,xx xFOR FOR PEER REVIEW Molecules 2022, 27, FOR PEER REVIEW Molecules 2022, PEER REVIEW of /2022/
• what: In this paper, based on different target proteins, the representative macrocyclic compounds used for the treatment of malignant tumors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.